SR-17018 (other name: SR17018) is an opioid analgesic, developed as an agonist of the µ-opioid receptor, by activating G-protein signaling pathways.
Pharmacology
This substance is relatively new and there is little data on its toxicological and pharmacological properties.
According to a rodent study, this perapart is an agonist of the m-opioid receptors, activating the G-protein pathway, while acting as an analgesic, causing a number of effects similar to common opioids such as morphine and buprenorphine, but with less respiratory depression, as shown by in vitro results.
Legal status
SR-17018 has an unclear legal status, this substance has been little studied. This substance is intended for research purposes in special laboratories in compliance with all procedures, standards and safety measures.
Product Name: SR-17018
Other Name(s): SR17018
IUPAC Name: 5,6-dichloro-3-[1-[(4-chlorophenyl)methyl]piperidin-4-yl]-1H-benzimidazol-2-one
CAS: 2134602-45-0
Molar Mass: 410.72 g·mol−1
Molecular Formula: C19H18Cl3N3O
InChi Code: InChI=1S/C19H18Cl3N3O/c20-13-3-1-12(2-4-13)11-24-7-5-14(6-8-24)25-18-10-16(22)15(21)9-17(18)23-19(25)26/h1-4,9-10,14H,5-8,11H2,(H,23,26)
InChIKey: LAGUDYUGRSQDKS-UHFFFAOYSA-N
Canonical SMILES: C1CN(CCC1N2C3=CC(=C(C=C3NC2=O)Cl)Cl)CC4=CC=C(C=C4)Cl
Formulation: A crystalline solid, Powder

Create a preliminary purchase request. Check stock availability. Communication with support:
Methiodone. HCL
Tianeptine Metabolite MC5-d4 Sodium Salt 













